Argenx Announces Full Exercise Of Underwriters' Option To Purchase Additional ADSs Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017 AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017 Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By August 23, 2017
Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017
AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017